✦ LIBER ✦

Individualized therapies in colorectal cancer: KRAS as a marker for response to EGFR-targeted therapy

✍ Scribed by David Z Chang; Vikas Kumar; Ying Ma; Kuiyuan Li; Scott Kopetz

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

KRAS gene amplification in colorectal ca

✍ Valtorta, Emanuele; Misale, Sandra; Sartore-Bianchi, Andrea; Nagtegaal, Iris D.; 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 French ⚖ 367 KB

KRAS mutation status in colorectal cance

✍ Rouleau, E; Spyratos, F; Dieumegard, B; Guinebretière, J M; Lidereau, R; Bièche, 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 50 KB

KRAS mutations in non-small-cell lung ca

✍ Maus, M.K.H.; Grimminger, P.P.; Mack, P.C.; Astrow, S.H.; Stephens, C.; Zeger, G 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 339 KB

A gene expression predictor of response

✍ Justin M Balko; Esther P Black 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 657 KB

Effect of low-frequency KRAS mutations o

✍ Tougeron, D.; Lecomte, T.; Pages, J. C.; Villalva, C.; Collin, C.; Ferru, A.; To 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 159 KB

140: MET signaling in colorectal cancer-

✍ Luraghi, P.; Reato, G.; Cipriano, E.; Menietti, E.; Sassi, F.; Bigatto, V.; Orza 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 64 KB